AI Article Synopsis

  • There is growing evidence linking onchocerciasis (a parasitic disease) to seizures, leading to the recognition of onchocerciasis-associated epilepsy (OAE) as a significant public health issue, especially in sub-Saharan Africa.
  • A recent workshop highlighted the need for a clear case definition of OAE and emphasized the importance of integrating epilepsy care into ongoing onchocerciasis elimination efforts to reduce the incidence of seizures.
  • Recommendations include enhancing collaboration between health programs, ensuring uninterrupted access to free anti-seizure medications in affected areas, and incorporating OAE into assessments of the overall onchocerciasis disease burden.

Article Abstract

Background: There is increasing epidemiological evidence supporting the association between onchocerciasis and seizures, reinforcing the concept of onchocerciasis-associated epilepsy (OAE). The aim of this paper is to provide an update on the new knowledge about OAE and to propose recommendations to the World Health Organization how to address this public health problem.

Main Text: During the 2nd International Workshop on OAE held on 19-21 September, 2023, in Antwerp, Belgium, participants recognised OAE as a substantial yet neglected public health problem, particularly in areas of sub-Saharan Africa where onchocerciasis remains hyperendemic. Evidence from prospective population-based studies suggest that strengthening onchocerciasis elimination efforts leads to a significant reduction of OAE incidence. There is a need to validate an OAE case definition to estimate the burden of disease and identify onchocerciasis-endemic areas requiring intensification of onchocerciasis elimination programmes and integration of epilepsy care. It is expected that raising awareness about OAE will boost the population uptake of ivermectin. The implementation of a community-based epilepsy treatment programme offering free anti-seizure medications (ASMs) has shown high effectiveness in reducing the frequency of seizures and improving the overall quality of life of people with epilepsy.

Conclusions: To reduce OAE burden, enhanced collaboration between onchocerciasis and mental health programmes at community, national, and international levels is required. Urgent efforts are needed to ensure the uninterrupted provision of free ASMs in onchocerciasis-endemic areas. Furthermore, OAE should be included in the quantification of the onchocerciasis disease burden.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10785461PMC
http://dx.doi.org/10.1186/s40249-024-01174-8DOI Listing

Publication Analysis

Top Keywords

onchocerciasis-endemic areas
12
oae
9
public health
8
onchocerciasis elimination
8
onchocerciasis
6
treatment prevention
4
epilepsy
4
prevention epilepsy
4
epilepsy onchocerciasis-endemic
4
areas
4

Similar Publications

Objective: In onchocerciasis-endemic areas, limited access to antiseizure medications (ASMs) contributes to a high epilepsy burden. This study evaluated the impact of a community-based epilepsy care program in Mahenge, Tanzania, an onchocerciasis-endemic area with high epilepsy prevalence.

Methods: A baseline survey (2017-2018) identified persons with epilepsy (PWE) in four rural villages.

View Article and Find Full Text PDF
Article Synopsis
  • - The survey in Gabon between January and February 2020 studied infections from geohelminths in five communities where onchocerciasis is common, confirming endemicity through IgG testing and detecting soil-transmitted helminths (STHs) using Kato-Katz methods.
  • - Results showed a high prevalence of STHs at 64.8%, particularly in hypoendemic (80.9%) and hyperendemic (63.9%) areas. Hookworms were more common among males, and adults faced higher infection rates (75.9%) compared to the elderly (39.3%).
  • - The study suggests that a combined approach for eliminating STHs and onchocerciasis, through
View Article and Find Full Text PDF
Article Synopsis
  • Moxidectin is FDA-approved for treating river-blindness in individuals aged 12 and older, and it's being considered for use in mass drug administration (MDA) programs to help control and potentially eliminate the disease.
  • Infants in onchocerciasis-endemic areas are often breastfed until age 2, raising concerns about the effects of moxidectin on nursing infants during MDA programs.
  • Studies show that moxidectin concentrations in breast milk peak around 4 hours post-dosing, but drop below safe exposure levels within two days, providing reassurance for prescribers regarding its use in lactating women.
View Article and Find Full Text PDF

Besides being vectors of the onchocerciasis parasite, blackflies are a source of nuisance in onchocerciasis-endemic communities. We investigated the experience of residents in the Ntui Health District (Cameroon) regarding blackfly nuisance and assessed their perceptions of a novel "Slash and Clear" (S&C) intervention for blackfly control. Focus group discussions were conducted before and after S&C implementation (respectively, in February 2022 and December 2023).

View Article and Find Full Text PDF
Article Synopsis
  • In 2018, the prevalence of epilepsy in Maridi County, South Sudan, was found to be 43.8 per 1000 persons, with a significant portion linked to onchocerciasis, leading to the establishment of an epilepsy clinic in 2020.
  • An evaluation in August 2023 showed that the clinic has increased the number of people with epilepsy (PWE) on anti-seizure medication by 39.7% and significantly reduced those experiencing daily seizures from 27.3% to 5.3%.
  • Although the clinic has made positive changes, stigma surrounding epilepsy remains high, highlighting the need for ongoing education and resources for PWE in endemic areas.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!